BioSpace News Archive

Genomic Vision (FR0011799907 – GV), a company specializing in the development of diagnostic tests for the early detection of cancers and hereditary diseases, and applications for life sciences research, today announces that it has entered into a licensing agreement with European Equity Partners (EEP), a U.K private investment firm focused on life science investments, to use molecular combing technology within the bioprocessing domain.

Nexus Health Capital’s Corporate Social Responsibility Program, recently announced by William Lautman, expands its scope to sponsor Golf Fore Africa to build a water-well in Zambia.

Welltower Inc. announced that it has successfully priced its offering of $1.3 billion in aggregate principal amount of senior unsecured notes across three tranches

PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, today announced that they are expanding operations in Indianapolis and building a new global headquarters.